PDGFRA and cancer: Furthermore, CNAs, as often reported in clinical samples (46,47), were detected in the regions of some cancer-related genes; for example, copy number gains of FGFR1, EGFR and PDGFRA in H1703, amplification of MYC and a homozygous loss of CDKN2A in LC2/ad (Figure 1B).